Olema Pharmaceuticals, Inc. - OLMA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 06, 2026 | SCHEDULE 13G/A | FMR LLC | 13.8% | 12,075,062 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 13.8% | 12,075,062 | View |
| Jul 29, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 7.1% | 6,244,212 | View |
| May 15, 2026 | SCHEDULE 13G/A | Bain Capital Life Sciences Opportunities IV, L.P. | 8.15% | 7,473,238 | View |
| May 15, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 8.2% | 7,108,488 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.